A trio of stocks made an impressive leap in their Benzinga Edge value scores this week, with one standout making a 138% jump.

DexCom (DXCM) is under the spotlight after several class action lawsuits were filed claiming the company made unauthorized changes to its G6 and G7 glucose monitoring devices. These changes could ...

Dexcom has issued a Class I recall for its G6 Android app due to crashes that could cause users to miss critical glucose ...

A software defect could cause the app to terminate, resulting in missed alerts or alarms. Dexcom required users to download ...

DexCom's third quarter was met with a negative market reaction despite outpacing Wall Street’s revenue and adjusted EPS ...

Shares of DexCom Inc. slipped 5.21% to $55.00 Friday, on what proved to be an all-around favorable trading session for the ...

DexCom, Inc. (NASDAQ:DXCM) Q3 2025 Earnings Call Transcript ... This includes active coverage for nearly 6 million type 2 non-insulin lives, which represents about half of the type 2 NIT commercial ...

Kessler Topaz Meltzer & Check, LLP encourages DexCom investors who have suffered significant losses to contact the firm directly to acquire more information. CLICK HERE TO SIGN UP FOR THE CASE OR GO ...

It's rare for an attractive dividend stock also to have growth potential. Most leading dividend distributors have moved past ...

The law firm of Kessler Topaz Meltzer & Check, LLP ( informs investors that a securities class action lawsuit has been ...

A video game maker faced pressure on Friday, Nov. 7, 2025, after delaying the release of a highly anticipated title, while ...

The CGM market is an exciting, fast-growing, multibillion-dollar medtech sector, according to our new Medtech Market ...